12
Nov
Final Results for the year ended 30 June 2014
Comments
Chairman’s Statement
Summary of Results in the year ended 30 June 2014
- The turnover of the Company increased by 12% to £267,903 (2013: £240,000).
- The operating loss reduced by 15% to £465,265 (2013: £548,342).
- On 30 June 2014 the surplus of shareholders’ funds was £136,487 (2013: £255,821).
This year, Physiomics has made good progress advancing Virtual Tumour Clinical and has broadened its offering into the personalised medicine market.
In summary we have...Read more